ZANTAC – CANCER LAWSUIT
ZANTAC – STOMACH AND BLADDER CANCER
Were you or a loved one diagnosed with stomach cancer or bladder cancer after taking Zantac?
The drug company Sandoz Inc., makers of Ranitidine Hydrochloride Capsules 150mg and 300 mg (Zantac), has issued a voluntary recall after confirming that the generic Zantac capsules contained an “unexpected impurity, N-Nitrosodimethylamine (NDMA),” which is a probable human carcinogen.
The U.S. Food and Drug Administration issued an advisory on Sept. 13, 2019, warning the public of a Zantac cancer risk due to chemical contamination of the heartburn medication. Although the FDA advisory states that the level of contamination is “low,” the levels have been found to be between 3,000 and 26,000 times higher than what the agency has determined to be “safe.”
The FDA explained that medicines containing ranitidine, including Zantac (ranitidine), contain trace amounts of n-nitrosodimethylamine (NDMA). Laboratory tests have demonstrated NDMA to be a potent carcinogen. Several Zantac recalls have been issued since contamination was first discovered. The first recall was issued on Sept. 23, 2019 by generic drug maker Sandoz. Several generic Zantac makers have also issued recalls including those that supply Zantac for Walgreens, Walmart, Rite Aid, and CVS. Sanofi, makers of brand name Zantac, also initiated a recall on Oct. 18, 2019. Drugmaker Novartis announced on Sept. 19 that it was stopping distribution of generic Zantac.
FDA officials are saying that people may continue to take Zantac and other ranitidine medications, but those who are on a prescription version should consult with their physicians in order to find out if an alternative treatment is available.
IMPORTANT ZANTAC UPDATE:
The U.S. Food and Drug Administration announced on April 1, 2020 that it is requesting manufacturers to withdraw all Zantac and generic Zantac OTC ranitidine drugs from the market effective immediately. The FDA determined that N-Nitrosodimethylamine (NDMA) in some ranitidine medications “increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…” The FDA, the Environmental Protection Agency (EPA), and the World Health Organization (WHO) all classify NDMA as a cancer-causing substance.
If you developed cancer after taking Zantac, call 844-944-3825 today for a free, no-obligation Zantac lawsuit evaluation.